Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm

Clinical trial condition

Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm

Explore clinical trials studying Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm trial results

Recruiting

Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies

NCT07523555

Conditions: BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details